Summary
PARTNER 1 demonstrated that patients at high risk of surgery had a similar mortality at 5 years with transcatheter versus surgical aortic valve replacement, while the CoreValve US Pivotal Trial showed that transcatheter aortic valve replacement reduced mortality at 2 years when compared with surgical aortic valve replacement. Observational data showed that patients treated with MitraClip had improvements in mitral regurgitation. The AATAC-AF study showed that catheter ablation is superior to amiodarone in treating persistent atrial fibrillation.
- AATAC-AF
- amiodarone
- catheter ablation
- CoreValve US Pivotal Trial
- PARTNER 1
- surgical aortic valve replacement
- Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy registry
- transcatheter aortic valve replacement
- transcatheter mitral valve repair
- NCT00530894
- NCT01240902
- NCT0072991
- cardiology & cardiovascular medicine clinical trials
- interventional techniques & devices
- © 2015 SAGE Publications
Tools
Percutaneous Treatment of Valvular Heart Disease, Atrial Fibrillation Examined in Various Studies
Permalink:
Table of contents
Cited By...
- No citing articles found.